Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.
about
We can do it together: PAR1/PAR2 heterodimer signaling in VSMCsProtease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosisMapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER StatusPH motifs in PAR1&2 endow breast cancer growth.Matrix metalloproteases and PAR1 activation.Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis.Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactG Protein-Coupled Receptor Heteromers.Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.Protease receptor antagonism to target blood platelet therapies.Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization.Coagulation and non-coagulation effects of thrombin.Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis.Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.Emerging roles for vascular smooth muscle cell exosomes in calcification and coagulation.Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice.Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin.Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay.Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.
P2860
Q35599925-69B42EAE-290E-4BF6-AC1F-A47A59827FC9Q35695573-4C78E9B4-6F26-40C7-894E-B4A077D86BBAQ35879995-3370F908-CB71-47A5-BD57-C498303DA49BQ35921287-01D38F98-382E-411B-868E-5A9449473BDFQ36357012-374139F7-AA4E-4126-B2AB-D8A21F0CA377Q36542806-32733D37-1957-45B3-B0EF-077785A6D55EQ36699691-0CB22658-48FA-489F-A41E-2338E01488CCQ36779515-F08B8077-7111-4E0F-BFFF-CBE09566FCC5Q37095396-42DD9A2F-CFF5-4672-A49D-77AFBFAB8E6AQ37348262-71539E01-8882-4FCB-875E-AC46C7CB03CAQ37489251-3538B6C7-7D4D-49C6-85E1-C0392616D322Q38175362-51D3F1A9-7251-40A4-8DEA-CF444078AEB0Q38616508-65F12093-FEBE-4D9F-BA1C-B301C39FAC58Q38728933-5416A457-2663-4C5B-89B4-F50B05BD1E96Q38924721-FBD08670-BA96-4AA7-9A09-6B9247E2C6C6Q39024744-B17FFB22-E1F9-4A45-96C0-1D689A24D96AQ39323119-DDD14016-D818-4B72-8F5D-A4537A10B560Q40006523-80709F0A-C663-4E8B-84FA-CE26BA88C830Q41546012-0C32EB17-D7CB-4EED-AE7F-8A21EB4C6254Q41673298-A966507D-9AFB-4D55-88CD-1DEB2D5307AFQ42725773-94BA70D8-67E8-450B-858C-06B61FD66512Q47313086-563B310E-EAF4-4FC7-B1B5-1F559B10F08BQ49754648-A183E804-B20B-4E8C-8000-C4E41CAF79B3Q52721277-558630B6-0465-4F7B-9595-2BE782A4EE4C
P2860
Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@ast
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@en
type
label
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@ast
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@en
prefLabel
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@ast
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@en
P2093
P2860
P1476
Protease-activated receptor-2 ...... driven neointimal hyperplasia.
@en
P2093
Athan Kuliopulos
Georgios Koukos
Karyn M Austin
Leila M Sevigny
Lidija Covic
Ping Zhang
Sheida Sharifi
Shogo Kasuda
P2860
P304
P356
10.1161/ATVBAHA.111.238261
P407
P577
2011-09-22T00:00:00Z